Public funding and pricing

The Norwegian Medicines Agency is responsible for setting maximum prices on prescription-only-medicines. The Agency also evaluates and decides whether a medicine should be publicly funded.

Much of the information on this website has recently been updated according to changes in regulations from January 1 2018.

Horizon scanning or request for assessment	https://legemiddelverket.no/english/public-funding-and-pricing/horizon-scanning	Horizon scanning or request for assessment	Horizon scanning shall ensure that new and important health technologies are identified and prioritised for health technology assessment.	1941
Pipeline- meetings	https://legemiddelverket.no/english/public-funding-and-pricing/pipeline-meetings	Pipeline- meetings	NOMA seeks to contribute to map new drugs and indications expected to be launched in Norway in the foreseeable future. As a step in this process, the pharmaceuticals companies are invited to take part in the pipeline meetings held by "Sykehusinnkjøp".	1951
Submission of documentation for single technology assessment of pharmaceuticals	https://legemiddelverket.no/english/public-funding-and-pricing/documentation-for-sta	Submission of documentation for single technology assessment of pharmaceuticals	All new pharmaceuticals with Marketing Authorisation are subject to a single technology assessment (STA) before they can be publicly funded either by the Regional Health Authorities (Nye metoder) or under the National Insurance Scheme (folketrygden).	1932	Guidelines and template for documentation.
Single technology assessments - status and reports	https://legemiddelverket.no/english/public-funding-and-pricing/single-technology-assessments-status-and-reports	Single technology assessments - status and reports	The current status of single technology assessments (STAs) and a list of STA reports.	1940
Maximum price	https://legemiddelverket.no/english/public-funding-and-pricing/maximum-price	Maximum price	Here you will find information about price applications and reevaluation of prices.	782
The Norwegian health care system and pharmaceutical system	https://legemiddelverket.no/english/about-us/the-norwegian-health-care-system-and-pharmaceutical-system	The Norwegian health care system and pharmaceutical system	An introcuction for foreigners with a comprehensive presentation of the pharmaceutical system, pricing and reimbursement in Norway.	436

Skriv ut

Public funding and pricing

Kontakt oss

Om Legemiddelverket